NAS:SLP (USA) Also Trade In: Germany
Simulations Plus Inc $ 74.61 1.42 (1.94%)
Warning! GuruFocus has detected 3 Severe warning signs with SLP. Click here to check it out.
Avg Vol (1m):
Market Cap $:
Enterprise Value $:
Current and historical daily P/E ratio for SLP (Simulations Plus Inc) from 1997 to Feb 25 2021. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The P/E ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the P/E ratio is positive. Also for stocks with the same P/E ratio, the one with faster growth business is more attractive. Simulations Plus stock (SLP) PE ratio as of Feb 25 2021 is 146.29. More Details
Simulations Plus PE Ratio (TTM) Historical Data
View and export this data going back to 1997. Start your Free Trial
Simulations Plus PE Ratio (TTM) Comparison
|Company||Market Cap(Mil)||PE Ratio (TTM)|
Compare NYSE:EVH NAS:HSTM NAS:NXGN NAS:SY NAS:MDRX NAS:HCAT NAS:CPSI NAS:NH NYSE:PHR NAS:ICAD NYSE:VEEV TSE:2413 NAS:CERN HKSE:01833 NYSE:TDOC NAS:TXG SZSE:300253 NAS:ONEM NAS:SDGR NAS:HQY
Address 42505 Tenth Street West, Lancaster, CA, USA, 93534-7059
Simulations Plus Inc is engaged in the software industry. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Simulations Plus, Inc; Cognigen Corporation; DILIsym, and Lixoft. It generates maximum revenue from Simulations Plus, Inc segment. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity) Predictor which is a computer program that takes molecular structures as inputs; MedChem Designer and MedChem Studio.